What is Psilocybin?
You might have heard of the hallucinogenic drug called ‘Magic Mushrooms’ which is referred to as psilocybin, but did you know that research may suggest that the psychedelic drug could be used to relieve some symptoms of depression? Recent studies have indicated that psilocybin may help in treating depression due to its action on the […]
Living with Eczema in the Summer
For people living with eczema, summer can be a tricky time. The heat and humidity can trigger flare ups while perspiration and sunscreen can be irritating to the skin. So what can be done to reduce flare ups during the summer months? Here at MAC Clinical Research, we have lots of experience with skin conditions […]
What is Drug Repositioning?
Developing a new medicine can be a very long process. In fact, on average, it takes ten to twelve years for a new medicine to complete its journey from initial discovery in the lab, to the marketplace. Therefore, alternative methods are often used that can speed up the process of finding new treatments for conditions. […]
Treating Mild Cognitive Impairment
Mild Cognitive Impairment (MCI) is a condition in which someone has some difficulty with cognition – so, their mental abilities like memory or thinking. It is estimated that between 5 and 20% of people aged over 65 have MCI. Those living with MCI struggle with cognitive tasks more than a healthy person at their age, […]
Living with Lewy Body Dementia
Dementia with Lewy bodies (DLB), also known as Lewy Body dementia, is one of the most common types of dementia. Like other memory illnesses, Lewy body dementia mainly affects people over 65 and causes problems with mental abilities, developing slowly and getting worse over several years. Lewy bodies are clumps of protein that can form […]
MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial for Major Depressive Disorder
Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase I/IIa clinical trial for its lead product, SPL026, a N,N-dimethyltryptamine (“DMT”) based treatment for major depressive disorder (“MDD”). MAC Clinical Research are proud to have been appointed the trial’s expansion with an additional study site at our Merseyside […]
Aducanumab for the treatment of Alzheimer’s
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the new drug Aducanumab for the treatment of Alzheimer’s, using its ‘accelerated approved pathway’, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments. It is the first new treatment approved for […]
What are Opioids?
Opioids are medications prescribed by doctors to treat persistent or severe pain. They can either be sourced synthetically or derived naturally from opium. Examples of opioids are morphine, codeine and tramadol. How do Opioid’s work? Opioids attach to proteins called opioid receptors on nerve cells in the brain and other parts of the body. When […]
What is OCD?
Obsessive-Compulsive Disorder (commonly referred to as OCD), is a mental health condition that affects around three quarters of a million people in the UK. People with OCD experience frequent, recurring thoughts (obsessions) and repetitive behaviours (compulsions) that they cannot control. OCD can be distressing and seriously interfere with day-to-day life, with many people feeling embarrassment […]
Illuminating Parkinson’s Awareness
In honour of this year’s Parkinson’s Awareness Week, the Ashton Memorial in Lancaster, UK has been illuminated blue, the colour representing Parkinson’s. The event has been organised by Parkinson’s UK volunteer and Lancaster resident Fiona Kennaugh. Fiona was diagnosed with early onset Parkinson’s in 2013 and has since been an active volunteer educator and campaigner […]